VIRX logo

Viracta Therapeutics (VIRX)

Profile

Full Name

Viracta Therapeutics, Inc.

Ticker Symbol

VIRX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

September 27, 2005

Indexes

Not included

Website

http://www.viracta.com

Employees

26

Key Details

Price

$0.02(0.00%)

Market cap

$794.88K(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$1.32(-1.54% YoY)

PE ratio

-

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.02
VIRX price is $0.02

30-Day Relative Volume

0.84
VIRX 30-day relative volume is 0.84

Price Performance

Price Most recent change

0%
VIRX {parameterFullLabel} has remained unchanged on Apr 11, 2025

Price YTD change

-87.5%
VIRX price is down -87.5% since January 1st

Price 1-year change

-98.26%
VIRX price is down -98.26% year-on-year

Price 3-year change

-99.51%
VIRX price is down -99.51% over the past 3 years

Price Range

Price All-time high

$9347.37
VIRX price is currently -100.00% below its historical high of $9347.37

Price 3-year low

$0.01
VIRX price is currently +100.00% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$794.88K
VIRX market capitalization is $794.88 thousand

Market cap 3-year change

-99.48%
VIRX market capitalization is down -99.48% over the past 3 years

Market cap All-time high

$580.82M
VIRX market capitalization is currently -99.86% below its historical high of $580.82 million

Market cap sector rank

3.53%
VIRX market capitalization is higher than 3.53% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+1.2%
VIRX shares outstanding is up +1.2% year-on-year

Shares Outstanding 3-Year Change

+6.02%
VIRX shares outstanding is up +6.02% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.87
VIRX beta is 0.87

200-day SMA

$0.21
VIRX price is currently -90.60% below its 200-day simple moving average

50-day SMA

$0.03
VIRX price is currently -30.07% below its 50-day simple moving average

RSI

42.86
VIRX 14-day relative strength index is 42.86

Volume

0.84
VIRX 30-day relative volume is 0.84

ATR

$0.01
VIRX average true range is $0.01

10-day Historical Volatility

362.54%
VIRX 10-day historical volatility is 362.54%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
VIRX annual revenue value is unknown

Revenue Analysts estimate

-
VIRX annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
VIRX annual revenue 1-year change is unknown

Revenue Sector rank

-
VIRX annual revenue is unknown

EPS

EPS

-$1.32
VIRX annual earnings per share is -$1.32

EPS Analysts estimate

-$0.90
VIRX annual earnings per share is currently +46.67% higher than the consensus analysts' forecast

EPS 1-year change

-1.54%
VIRX annual earnings per share is down -1.54% year-on-year

EPS Sector rank

49.22%
VIRX annual earnings per share is higher than 49.22% of companies in Healthcare sector

Profit

Gross profit

-
VIRX annual gross profit value is unknown

Gross margin

-
VIRX annual gross profit margin value is unknown

Operating profit

-$50.69M
VIRX annual operating income is -$50.69 million

Operating margin

-
VIRX annual operating profit margin value is unknown

Net income

-$51.06M
VIRX annual net profit is -$51.06 million

Net margin

-
VIRX annual net profit margin value is unknown

Expenses

Total expenses

$50.69M
VIRX annual total expenses is $50.69 million

Operating expenses

$50.69M
VIRX annual total operating expenses is $50.69 million

Cost of goods sold

-
VIRX annual cost of goods sold value is unknown

Selling, general & administrative expenses

$17.32M
VIRX annual SGA is $17.32 million

Depreciation and amortization

$492.00K
VIRX annual depreciation & amortization is $492.00 thousand

Interest expense

$3.70M
VIRX annual interest expense is $3.70 million

Income tax

-
VIRX annual income tax value is unknown

EBIT & EBITDA

EBIT

-$47.35M
VIRX annual earnings before interest & taxes is -$47.35 million

EBITDA

-$46.86M
VIRX annual EBITDA is -$46.86 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$56.69M
VIRX annual total assets is $56.69 million

Non current assets

$1.73M
VIRX annual long term assets is $1.73 million

Current assets

$54.96M
VIRX annual total current assets is $54.96 million

Cash and cash equivalents

$12.32M
VIRX annual cash & cash equivalents is $12.32 million

Accounts receivable

-
VIRX annual accounts receivable value is unknown

Inventory

-
VIRX annual inventory value is unknown

Liabilities

Total liabilities

$38.37M
VIRX annual total liabilities is $38.37 million

Long term liabilities

$0.00
VIRX annual total long term liabilities is $0.00

Current liabilities

$38.37M
VIRX annual total current liabilities is $38.37 million

Accounts payable

$2.44M
VIRX annual accounts payable is $2.44 million

Debt

Total debt

$25.56M
VIRX annual total debt is $25.56 million

Total debt 1-year change

+1.59%
VIRX annual total debt is up +1.59% year-on-year

Long term debt

-
VIRX annual long term debt value is unknown

Short term debt

$25.56M
VIRX annual short term debt is $25.56 million

Equity & Capital

Shareholders equity

$18.32M
VIRX annual stockholders equity is $18.32 million

Book value

$12.87M
VIRX annual book value is $12.87 million

Retained earnings

-$265.93M
VIRX annual retained earnings is -$265.93 million

Working capital

$16.59M
VIRX annual working capital is $16.59 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$39.89M
VIRX annual cash flow from operations is -$39.89 million

Cash from operations 1-year change

-12.51%
VIRX annual cash flow from operations is down -12.51% year-on-year

Cash from investing

$15.00M
VIRX annual cash flow from investing activities is $15.00 million

Cash from investing 1-year change

+127.84%
VIRX annual cash flow from investing activities is up +127.84% year-on-year

Cash from financing

$438.00K
VIRX annual cash flow from financing activities is $438.00 thousand

Cash from financing 1-year change

-98.06%
VIRX annual cash flow from financing activities is down -98.06% year-on-year

CAPEX

CAPEX

-
VIRX annual capital expenditures value is unknown

CAPEX 1-year change

-
VIRX annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$40.03M
VIRX annual free cash flow is -$40.03 million

Free cash flow 1-year change

-12.75%
VIRX annual free cash flow is down -12.75% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
VIRX annual gross profit margin value is unknown

Operating margin

-
VIRX annual operating profit margin value is unknown

Net margin

-
VIRX annual net profit margin value is unknown

ROA & ROE

ROA

-90.06%
VIRX annual return on assets is -90.06%

ROE

-278.72%
VIRX annual return on equity is -278.72%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
VIRX price to earnings ratio value is unknown

PE ratio Sector rank

-
VIRX price to earnings ratio is unknown

PB Ratio

PB ratio

-0.12
VIRX price to book ratio is -0.12

PB ratio Sector rank

12.83%
VIRX price to book ratio is higher than 12.83% of companies in Healthcare sector

PS Ratio

PS ratio

-
VIRX price to sales ratio value is unknown

PS ratio Sector rank

-
VIRX price to sales ratio is unknown

Enterprise value

Enterprise value

$4.58M
VIRX enterprise value is $4.58 million

Enterprise value Sector rank

19.49%
VIRX enterprise value is higher than 19.49% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.12
VIRX EV/EBITDA is -0.12

EV/EBITDA Sector rank

60.3%
VIRX EV/EBITDA is higher than 60.3% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.43
VIRX annual current ratio is 1.43

Quick ratio

-
VIRX annual quick ratio value is unknown

Leverage

Debt to equity

1.40
VIRX annual debt to equity ratio is 1.40

Interest coverage ratio

-12.78
VIRX annual interest coverage ratio is -12.78

Risk & Stability

Piotroski F-Score

-
VIRX piotroski f-score value is unknown

Altman Z-Score

-
VIRX altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Dec 27, 24 Rodman & Renshaw
Neutral
Nov 14, 24 RBC Capital
Outperform
Aug 16, 24 Leerink Partners
Market Perform
Aug 15, 24 RBC Capital
Outperform
May 23, 24 Oppenheimer
Outperform
Apr 17, 24 Oppenheimer
Outperform
Apr 16, 24 HC Wainwright & Co.
Buy
Mar 12, 24 HC Wainwright & Co.
Buy
Jan 5, 24 HC Wainwright & Co.
Buy
Nov 10, 23 RBC Capital
Outperform

Institutional Ownership

Similar stocks

ATXI logo
Avenue Therapeutics (ATXI)
TNF Pharmaceuticals (TNFA)
NEPT logo
Neptune Wellness Solutions (NEPT)
NIVF logo
NewGenIvf Group Limited (NIVF)
SCPX logo
Scorpius Holdings (SCPX)
SYRS logo
Syros Pharmaceuticals (SYRS)
TRVN logo
Trevena (TRVN)
LGMK logo
LogicMark (LGMK)
BIOR logo
Biora Therapeutics (BIOR)
  • What is the ticker symbol for Viracta Therapeutics?
  • Does Viracta Therapeutics pay dividends?
  • What sector is Viracta Therapeutics in?
  • What industry is Viracta Therapeutics in?
  • What country is Viracta Therapeutics based in?
  • When did Viracta Therapeutics go public?
  • Is Viracta Therapeutics in the S&P 500?
  • Is Viracta Therapeutics in the NASDAQ 100?
  • Is Viracta Therapeutics in the Dow Jones?
  • When was Viracta Therapeutics's last earnings report?
  • When does Viracta Therapeutics report earnings?
  • Should I buy Viracta Therapeutics stock now?

What is the ticker symbol for Viracta Therapeutics?

The ticker symbol for Viracta Therapeutics is NASDAQ:VIRX

Does Viracta Therapeutics pay dividends?

No, Viracta Therapeutics does not pay dividends

What sector is Viracta Therapeutics in?

Viracta Therapeutics is in the Healthcare sector

What industry is Viracta Therapeutics in?

Viracta Therapeutics is in the Biotechnology industry

What country is Viracta Therapeutics based in?

Viracta Therapeutics is headquartered in United States

When did Viracta Therapeutics go public?

Viracta Therapeutics's initial public offering (IPO) was on September 27, 2005

Is Viracta Therapeutics in the S&P 500?

No, Viracta Therapeutics is not included in the S&P 500 index

Is Viracta Therapeutics in the NASDAQ 100?

No, Viracta Therapeutics is not included in the NASDAQ 100 index

Is Viracta Therapeutics in the Dow Jones?

No, Viracta Therapeutics is not included in the Dow Jones index

When was Viracta Therapeutics's last earnings report?

Viracta Therapeutics's most recent earnings report was on Nov 13, 2024

When does Viracta Therapeutics report earnings?

The next expected earnings date for Viracta Therapeutics is May 9, 2025

Should I buy Viracta Therapeutics stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page